← FDA DRUG APPROVALS

FDA ANDA · ANDA065163

DOXYCYCLINE HYCLATE

Sponsor: HERITAGE PHARMA

APPLICATION
ANDA065163
TYPE
ANDA
ORIGINAL APPROVAL
2005-05-13
LATEST ACTION
2025-03-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 20MG BASE · TABLET · ORAL

Approval history

2025-03-31Labeling · Supplement 14 · standardAP
2025-03-12Labeling · Supplement 13 · standardAP
2025-03-12Labeling · Supplement 12 · standardAP
2005-05-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →